Boston Scientific announced today that it completed its previously announced acquisition of SoniVie. In March, Boston Scientific announced that it agreed to acquire the intravascular ultrasound system developer. This acquisition brings Boston Scientific into the now-competitive renal denervation (RDN) space. Recor Medical received a landmark FDA nod for its Paradise ultrasound-based RDN system in November 2023. […]
Mergers & Acquisitions
ElectroCore completes acquisition of NeuroMetrix
ElectroCore (Nasdaq:ECOR) announced today that it completed its previously announced acquisition of NeuroMetrix (Nasdaq:NURO). In December 2024, Rockaway, New Jersey-based ElectroCore struck a deal to acquire NeuroMetrix and its neuromodulation platform. Quell, a solution for treating fibromyalgia and lower-extremity chronic pain, adds to ElectroCore’s portfolio of non-invasive bioelectronic therapies. ElectroCore expects the wearable, app- and […]
HistoSonics reportedly eyes sale at $2.5B valuation with Medtronic, GE HealthCare, J&J interest
The Financial Times reports today that histotripsy platform developer HistoSonics is considering a potential sale after receiving a number of offers. According to the report, the valuation for the potential deal comes in at more than $2.5 billion. Citing people familiar with the matter, FT says Medtronic, GE HealthCare and Johnson & Johnson are circling […]
Resmed acquires virtual diagnostics company VirtuOx
Resmed announced today that it acquired VirtuOx, a leading independent diagnostic testing facility (IDTF). VirtuOx provides diagnostic services for sleep, respiratory and cardiac conditions. San Diego-based Resmed, a leader in sleep apnea therapy and digital offerings, says the acquisition reflects its commitment to making care more accessible, more coordinated and more patient-friendly. According to a […]
Ypsomed to sell diabetes business, insulin delivery tech to TecMed for $517.7M
Ypsomed is shifting its focus to the subcutaneous self-injection market through the planned sale of its diabetes business to TecMed. Our sister site, Drug Delivery Business News, reports today that the Swiss medtech company agreed to sell the unit for about $517.7 million. Included in the sale are the Ypsomed Diabetes Care unit’s relevant subsidiaries and […]
Zimmer Biomet completes Paragon 28 acquisition
Zimmer Biomet announced today that it has completed its $1.2 billion purchase of Paragon 28. Announced in January, the deal represents a significant play in the foot and ankle treatment space for ZB. Established in 2010, Paragon 28 has a wide suite of surgical offerings and product systems spanning all major foot and ankle segments, […]
RadNet to acquire iCad
RadNet (Nasdaq:RDNT) announced an agreement to acquire iCad (Nasdaq:ICAD) in an all-stock transaction for approximately $103 million. Under the agreement, iCad stockholders receive 0.0677 shares of RadNet common stock for each iCad share held at closing. Based on RadNet’s closing price on Monday, April 14, 2025, this brings the transaction’s value to approximately $103 million. […]
Kandu Health, Neurolutions merge into BCI company targeting stroke care
Kandu Health and Neurolutions announced today that they merged to form Kandu Inc. to set a new standard of care for stroke recovery. The companies aim to deliver a first-of-its-kind, end-to-end solution for stroke survivors. They seek to combine brain-computer interface (BCI) technology with personalized telehealth services. Kandu, a former Imperative care subsidiary that spun […]
Owens & Minor prices upsized $1B offering
Owens & Minor (NYSE:OMI) announced that it upsized and priced an offering of $1 billion in senior secured notes due 2030. The Richmond, Virginia-based company said the notes bear interest at the rate of 10% per year and mature on April 15, 2030. It expects the offering to close today, April 4, 2025. Unless the […]
Globus Medical completes acquisition of Nevro
Globus Medical (NYSE:GMED) announced today that that it completed its previously announced acquisition of Nevro. In February, Audobon, Pennsylvania-based Globus agreed to acquire all shares of Nevro in an all-cash transaction. Terms include a payment of $5.85 per share, with the deal’s total equity value reaching approximately $250 million. “We are excited to begin the […]
Boston Scientific closes Bolt Medical acquisition
Boston Scientific announced on social media that it completed its previously announced acquisition of Bolt Medical. News of the acquisition’s closing comes just days after the FDA granted 510(k) clearance for the Bolt IVL system on March 25, about two months post-submission (Jan. 27). The company wrote on LinkedIn: “We have successfully closed the acquisition […]
